Project 1: The Impact of Changing Tobacco Product Use on Tobacco-Relate p167-193

项目 1：改变烟草产品使用对烟草相关的影响 p167-193

• 批准号: 8754518
• 负责人: WENDY B MAX
• 金额: $ 51.39万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8754518
• 关键词: Accounting; Affect; Cardiovascular Diseases; Cigar; Cigarette; Complex; Computer Simulation; Data; Economic Models; Economics; Elderly; Environmental Tobacco Smoke; Expenditure; Health; Health Care Costs; Healthcare; Individual; Instruction; Longitudinal Surveys; Lung diseases; Menthol; Modeling; Oral Tobacco; Perception; Policies; Policy Analysis; Population; Prevalence; Regulation; Research; Risk; Simulate; Smoke; Smoking; Smoking and Health Research; Surveys; Time; Time Series Analysis; Tobacco; Tobacco use; Update; cigarette smoking; cost; economic cost; economic impact; improved; lung injury; non-smoking; risk perception; snuff; young adult

An important component of any regulation of tobacco products the FDA issues is an economic analysis of the regulation. Models of the health-related economic costs of cigarette smoking have evolved and improved over the years, and current models take into account the complex relationship between smoking, health, and healthcare expenditures. However, there is a lack of research on healthcare costs attributable to the use of tobacco products other than cigarettes. It is important to have this information given the increased rates at which non-cigarette products are being used. To fill this gap, we propose to develop models to estimate the healthcare costs (i.e. healthcare expenditures) resulting from the use of different tobacco products, including cigars, moist snuff, chewing tobacco, menthol and nonmenthol cigarettes, combinations of these products, and secondhand smoke exposure. Specifically, we plan to use individual level data from national surveys to 1) develop microeconomic models to estimate the healthcare costs attributable to the use of different tobacco products to determine whether the kind of product substantially affects costs and 2) develop microeconomic models to estimate the healthcare costs attributable to secondhand smoke exposure. These models will allow us to evaluate the impact of potential FDA regulations on healthcare costs through the projected changes in tobacco product use and secondhand smoke exposure using three alternative approaches (time senes analysis with data from national surveys, longitudinal model analysis with the PATH data, and simulated changes in tobacco product use prevalence) and through incorporating mathematical simulation models of short-term risks of pulmonary and cardiovascular diseases. Our models will incorporate findings from other TCORS projects, including the impact of nsk perception on use of different tobacco products among young adults and older adults, and studies ofthe effects of tobacco products on lung injury and cardiovascular disease in the short-term. Having better models ofthe cost of smoking and models of costs associated with the use of other tobacco products will be useful for the regulation of tobacco products because policy analysis needs to consider the impact of regulations on tobacco consumption as well as costs. RELEVANCE (See instructions): We will develop, for the first time, estimates of the healthcare costs associated with the use of menthol cigarettes, cigars, moist snuff, and chewing tobacco as well as updated and improved estimates ofthe cost of cigarette smoking and secondhand smoke exposure. We will use an individual-level microeconomic cost model framework that improves upon the economic model used previously by the FDA. The models also can be used to evaluate the impact on healthcare expenditures of other policies that impact tobacco product use.

FDA 发布的任何烟草产品法规的一个重要组成部分是对以下因素的经济分析： 的规定。吸烟与健康相关的经济成本模型已经发展和改进 多年来，当前的模型考虑了吸烟、健康和健康之间的复杂关系 医疗保健支出。然而，缺乏对使用医疗保健费用的研究。 香烟以外的烟草制品。鉴于费率增加，了解此信息非常重要 正在使用哪些非香烟产品。为了填补这一空白，我们建议开发模型来估计 由于使用不同烟草制品而产生的医疗保健费用（即医疗保健支出），包括 雪茄、湿鼻烟、咀嚼烟草、薄荷醇和非薄荷醇香烟、这些产品的组合， 和二手烟暴露。具体来说，我们计划使用全国调查中的个人层面数据来 1）开发微观经济模型来估计由于使用不同的医疗保健成本 烟草产品，以确定该产品是否对成本产生重大影响，并 2) 开发 微观经济模型来估计二手烟暴露造成的医疗保健成本。这些 模型将使我们能够通过以下方式评估潜在的 FDA 法规对医疗保健成本的影响： 使用三种替代方案预计烟草制品使用和二手烟暴露的变化 方法（利用国家调查数据进行时间分析、利用 PATH 进行纵向模型分析） 数据和烟草产品使用流行率的模拟变化）并通过结合数学 肺部和心血管疾病短期风险的模拟模型。我们的模型将包含 其他 TCORS 项目的调查结果，包括 nsk 认知对不同烟草使用的影响 年轻人和老年人的产品，以及烟草产品对肺损伤影响的研究 以及短期内的心血管疾病。拥有更好的吸烟成本模型和吸烟成本模型 与使用其他烟草制品相关的成本将有助于烟草制品的监管 因为政策分析需要考虑法规对烟草消费的影响以及 成本。 相关性（参见说明）： 我们将首次对与使用薄荷醇相关的医疗费用进行估算 香烟、雪茄、湿鼻烟和咀嚼烟草以及更新和改进的成本估算 吸烟和接触二手烟的情况。我们将使用个人层面的微观经济成本 模型框架改进了 FDA 之前使用的经济模型。模型还可以 用于评估影响烟草产品使用的其他政策对医疗保健支出的影响。